• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受持续肾脏替代治疗的危重症儿童血清磷与死亡率之间的关系。

Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy.

作者信息

Zhou Xiong, He Jie, Zhu Desheng, Yao Zhenya, Peng Dan, Zhang Xinping

机构信息

Pediatric Department of Critical Care Medicine, Hunan Children's Hospital, Changsha, China.

出版信息

Front Pediatr. 2023 Apr 12;11:1129156. doi: 10.3389/fped.2023.1129156. eCollection 2023.

DOI:10.3389/fped.2023.1129156
PMID:37124175
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10130528/
Abstract

PURPOSE

We aimed to explore the relationship between serum phosphate concentration and 90-day mortality in critically ill children receiving continuous renal replacement therapy (CRRT).

METHODS

Data from the medical records of children aged <13 years who received CRRT at the Pediatric Intensive Care Unit of Hunan Children's Hospital, China from January 2015 to June 2020 were retrospectively collected. Children were grouped into four categories according to the baseline phosphate concentration before CRRT and mean serum phosphate concentration during CRRT: <0.81 mmol/L (hypophosphatemia), 0.81-1.19 mmol/L, 1.2-2.4 mmol/L (normal phosphate concentration), and >2.4 mmol/L (hyperphosphatemia), with the normal phosphate group serving as the comparator group. The correlation of the serum phosphate concentration before and during CRRT with the 90-day mortality after CRRT initiation was analyzed using logistic regression.

RESULTS

A total of 177 children were included in our study. The mean serum phosphate concentration before CRRT was 1.46 mmol/L (quartiles: 1.04, 2.20). The 90-day mortality rate was increased in children with a serum phosphate concentration >2.4 mmol/L before CRRT (adjusted odds ratio [aOR] 3.74, 95% confidence interval [CI] 1.42-9.86,  = 0.008). The mean serum phosphate concentration during CRRT was 1.2 mmol/L (quartiles: 0.91, 1.49). The 90-day mortality rate was increased in children with a mean serum phosphate concentration >2.4 mmol/L during CRRT (aOR 7.34, 95% CI 1.59-33.88,  = 0.011).

CONCLUSION

Hyperphosphatemia before and during CRRT predicts a higher 90-day mortality rate.

摘要

目的

我们旨在探讨接受持续肾脏替代治疗(CRRT)的危重症儿童血清磷酸盐浓度与90天死亡率之间的关系。

方法

回顾性收集2015年1月至2020年6月在中国湖南省儿童医院儿科重症监护病房接受CRRT的13岁以下儿童的病历数据。根据CRRT前的基线磷酸盐浓度和CRRT期间的平均血清磷酸盐浓度,将儿童分为四类:<0.81 mmol/L(低磷血症)、0.81-1.19 mmol/L、1.2-2.4 mmol/L(正常磷酸盐浓度)和>2.4 mmol/L(高磷血症),以正常磷酸盐组作为对照组。采用逻辑回归分析CRRT前和期间的血清磷酸盐浓度与CRRT开始后90天死亡率的相关性。

结果

我们的研究共纳入177名儿童。CRRT前的平均血清磷酸盐浓度为1.46 mmol/L(四分位数:1.04,2.20)。CRRT前血清磷酸盐浓度>2.4 mmol/L的儿童90天死亡率增加(调整优势比[aOR] 3.74,95%置信区间[CI] 1.42-9.86,P = 0.008)。CRRT期间的平均血清磷酸盐浓度为1.2 mmol/L(四分位数:0.91,1.49)。CRRT期间平均血清磷酸盐浓度>2.4 mmol/L的儿童90天死亡率增加(aOR 7.34,95% CI 1.59-33.88,P = 0.011)。

结论

CRRT前和期间的高磷血症预示着90天死亡率更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b067/10130528/4a6b1ae02456/fped-11-1129156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b067/10130528/340fc365b829/fped-11-1129156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b067/10130528/47773eb1d53c/fped-11-1129156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b067/10130528/4a6b1ae02456/fped-11-1129156-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b067/10130528/340fc365b829/fped-11-1129156-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b067/10130528/47773eb1d53c/fped-11-1129156-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b067/10130528/4a6b1ae02456/fped-11-1129156-g003.jpg

相似文献

1
Relationship between serum phosphate and mortality in critically ill children receiving continuous renal replacement therapy.接受持续肾脏替代治疗的危重症儿童血清磷与死亡率之间的关系。
Front Pediatr. 2023 Apr 12;11:1129156. doi: 10.3389/fped.2023.1129156. eCollection 2023.
2
Association of Serum Phosphate Derangement With Mortality in Patients on Continuous Renal Replacement Therapy.接受持续肾脏替代治疗患者的血清磷酸盐紊乱与死亡率的关联
Can J Kidney Health Dis. 2022 Jul 26;9:20543581221114697. doi: 10.1177/20543581221114697. eCollection 2022.
3
Phosphate supplementation for hypophosphatemia during continuous renal replacement therapy in adults.成人连续性肾脏替代治疗中低磷血症时的磷酸盐补充。
Ren Fail. 2019 Nov;41(1):72-79. doi: 10.1080/0886022X.2018.1561374.
4
The Prognostic Importance of Serum Sodium for Mortality among Critically Ill Patients Requiring Continuous Renal Replacement Therapy.血清钠对需要持续肾脏替代治疗的危重症患者死亡率的预后重要性。
Nephron. 2022;146(2):153-159. doi: 10.1159/000519686. Epub 2021 Nov 18.
5
Association of Phosphate Containing Solutions with Incident Hypophosphatemia in Critically Ill Patients Requiring Continuous Renal Replacement Therapy.含磷溶液与需要连续性肾脏替代治疗的危重症患者并发低磷血症的关联。
Blood Purif. 2022;51(2):122-129. doi: 10.1159/000514418. Epub 2021 Apr 29.
6
Association of serum potassium derangements with mortality among patients requiring continuous renal replacement therapy.血清钾紊乱与需要持续肾脏替代治疗的患者死亡率的关系。
Ther Apher Dial. 2022 Dec;26(6):1098-1105. doi: 10.1111/1744-9987.13804. Epub 2022 Feb 14.
7
Association of hypochloremia with mortality among patients requiring continuous renal replacement therapy.需要持续肾脏替代治疗的患者中低氯血症与死亡率的关联。
J Nephrol. 2023 Jan;36(1):161-170. doi: 10.1007/s40620-022-01305-0. Epub 2022 Mar 26.
8
First 24-Hour Potassium Concentration and Variability and Association with Mortality in Patients Requiring Continuous Renal Replacement Therapy in Intensive Care Units: A Hospital-Based Retrospective Cohort Study.重症监护病房中需要持续肾脏替代治疗的患者的首个24小时血钾浓度、变异性及其与死亡率的关联:一项基于医院的回顾性队列研究
J Clin Med. 2022 Jun 13;11(12):3383. doi: 10.3390/jcm11123383.
9
Continuous venovenous hemodiafiltration with a low citrate dose regional anticoagulation protocol and a phosphate-containing solution: effects on acid-base status and phosphate supplementation needs.连续静脉-静脉血液透析滤过联合低剂量枸橼酸盐局部抗凝方案和含磷酸盐溶液:对酸碱平衡状态和磷酸盐补充需求的影响。
BMC Nephrol. 2013 Oct 25;14:232. doi: 10.1186/1471-2369-14-232.
10
The association between albumin corrected anion gap and ICU mortality in acute kidney injury patients requiring continuous renal replacement therapy.白蛋白校正阴离子间隙与连续性肾脏替代治疗的急性肾损伤患者 ICU 死亡率的关系。
Intern Emerg Med. 2022 Nov;17(8):2315-2322. doi: 10.1007/s11739-022-03093-8. Epub 2022 Sep 16.

引用本文的文献

1
Magnesium disturbances in critically ill children.危重症患儿的镁紊乱
Sci Rep. 2025 May 21;15(1):17620. doi: 10.1038/s41598-025-02288-1.
2
Efficacy of haemoadsorption combined with continuous renal replacement therapy in patients with rhabdomyolysis and acute kidney injury: a retrospective study.血液吸附联合连续性肾脏替代疗法治疗横纹肌溶解症合并急性肾损伤患者的疗效:一项回顾性研究
Clin Kidney J. 2024 Dec 17;18(2):sfae406. doi: 10.1093/ckj/sfae406. eCollection 2025 Feb.
3
Association Between the Serum Phosphate Levels and Hospital Mortality as Well as 90-Day Mortality Among Critically Ill Patients with Chronic Obstructive Pulmonary Disease: A Retrospective Cohort Study.

本文引用的文献

1
Association of Serum Phosphate Derangement With Mortality in Patients on Continuous Renal Replacement Therapy.接受持续肾脏替代治疗患者的血清磷酸盐紊乱与死亡率的关联
Can J Kidney Health Dis. 2022 Jul 26;9:20543581221114697. doi: 10.1177/20543581221114697. eCollection 2022.
2
Hyperphosphatemia and Outcomes in Critically Ill Patients: A Systematic Review and Meta-Analysis.危重症患者的高磷血症及其预后:一项系统评价和荟萃分析。
Front Med (Lausanne). 2022 May 17;9:870637. doi: 10.3389/fmed.2022.870637. eCollection 2022.
3
Disorders of phosphate homeostasis in children, part 2: hypophosphatemic and hyperphosphatemic disorders.
血清磷酸盐水平与慢性阻塞性肺疾病重症患者住院死亡率和 90 天死亡率的关系:一项回顾性队列研究。
Int J Chron Obstruct Pulmon Dis. 2024 Jul 18;19:1681-1693. doi: 10.2147/COPD.S465752. eCollection 2024.
儿童磷代谢紊乱,第 2 部分:低磷血症和高磷血症性疾病。
Pediatr Radiol. 2022 Nov;52(12):2290-2305. doi: 10.1007/s00247-022-05373-z. Epub 2022 May 10.
4
Disorders of phosphate homeostasis in children, part 1: primer on mineral ion homeostasis and the roles of phosphate in skeletal biology.儿童磷酸盐稳态紊乱,第 1 部分:矿物质离子稳态概论及磷酸盐在骨骼生物学中的作用。
Pediatr Radiol. 2022 Nov;52(12):2278-2289. doi: 10.1007/s00247-022-05374-y. Epub 2022 May 10.
5
Microparticles from Hyperphosphatemia-Stimulated Endothelial Cells Promote Vascular Calcification Through Astrocyte-Elevated Gene-1.高磷刺激的内皮细胞来源的微粒通过星形细胞增强基因-1 促进血管钙化。
Calcif Tissue Int. 2022 Jul;111(1):73-86. doi: 10.1007/s00223-022-00960-6. Epub 2022 Feb 23.
6
Hyperphosphatemia-induced degradation of transcription factor EB exacerbates vascular calcification.高磷血症诱导转录因子 EB 的降解加剧血管钙化。
Biochim Biophys Acta Mol Basis Dis. 2022 Mar 1;1868(3):166323. doi: 10.1016/j.bbadis.2021.166323. Epub 2021 Dec 16.
7
Association between serum phosphate and mortality in critically ill patients: a large retrospective cohort study.血清磷酸盐与危重症患者死亡率的关系:一项大型回顾性队列研究。
BMJ Open. 2021 Sep 6;11(9):e044473. doi: 10.1136/bmjopen-2020-044473.
8
Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease-A Pediatric Perspective.成纤维细胞生长因子23与慢性肾脏病中的左心室肥厚——儿科视角
Front Pediatr. 2021 Aug 4;9:702719. doi: 10.3389/fped.2021.702719. eCollection 2021.
9
Iron status, fibroblast growth factor 23 and cardiovascular and kidney outcomes in chronic kidney disease.慢性肾脏病患者的铁状态、成纤维细胞生长因子 23 与心血管及肾脏结局。
Kidney Int. 2021 Dec;100(6):1292-1302. doi: 10.1016/j.kint.2021.07.013. Epub 2021 Jul 30.
10
Association of Phosphate Containing Solutions with Incident Hypophosphatemia in Critically Ill Patients Requiring Continuous Renal Replacement Therapy.含磷溶液与需要连续性肾脏替代治疗的危重症患者并发低磷血症的关联。
Blood Purif. 2022;51(2):122-129. doi: 10.1159/000514418. Epub 2021 Apr 29.